Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Mol Cancer Ther. 2015 Aug;14(8):1767-76. doi: 10.1158/1535-7163.MCT-14-0636.…
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
PLoS One. 2015 May 8;10(5):e0123830. doi: 10.1371/journal.pone.0123830.…
LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET
Mol Carcinog. 2016 May;55(5):411-9. doi: 10.1002/mc.22289. Epub…
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
Pharmacogenomics J. 2014 Oct;14(5):424-31. doi: 10.1038/tpj.2014.16.…
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Nat Commun. 2014 Apr 3;5:3608. doi: 10.1038/ncomms4608.ABSTRACTCancer…
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis
J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857.…
Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer
J Natl Cancer Inst. 2014 Jan;106(1):djt322. doi: 10.1093/jnci/djt322.…
Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer
Med Oncol. 2013 Mar;30(1):428. doi: 10.1007/s12032-012-0428-0.…
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis
Clin Cancer Res. 2011 Mar 15;17(6):1632-40. doi: 10.1158/1078-0432.CCR-10-2169.…
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
Br J Cancer. 2010 Aug 10;103(4):581-9. doi: 10.1038/sj.bjc.6605776.…
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
Mol Cancer Ther. 2009 Apr;8(4):771-8. doi: 10.1158/1535-7163.MCT-08-0882.ABSTRACTWe…
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
Int J Cancer. 2009 Jun 15;124(12):2905-10. doi: 10.1002/ijc.24273.ABSTRACTRecently,…
